Medicines, vaccines and other medical products must be deemed essential as per inclusion in the most recent versions of the WHO Essential Medicines List or PAHO Strategic Fund. Medicines that are not listed as ‘essential’ may be considered based on public health need or value to CARICOM. Applicants are advised to contact the CRS to enquire about the eligibility of unlisted medicines.
WHO Pre-Qualified Medicines, Vaccines and Biotherapeutic Products
The CRS accepts applications for review of finished products prequalified by the World Health Organization (WHO). Applicants are advised to utilize the WHO Collaborative Procedure for the submission of key documents, and expedited review.
Pharmaceutical Products Recommended By A Reference Authority
Small molecule medicines, biotherapeutic medicines and vaccines that have been assessed by a recognized regulatory authority or agency of reference.
Emergency Use Listing
Medicines or vaccines that have been:
(i) included in the WHO Emergency Use Listing for COVID19, or
(ii) granted emergency use authorization for treatment or prevention of COVID-19 by a recognized regulatory authority or agency of reference.